Thoracic aortic aneurysm & aortopathy surveillance
TAA monitoring · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Thoracic aortic aneurysms involve the aortic root, ascending, arch or descending aorta and may be degenerative or linked to connective-tissue disease or bicuspid valve. Surveillance, blood-pressure control and size- or syndrome-based surgical referral prevent catastrophic dissection or rupture.
Red flags
- Sudden tearing chest/back pain (dissection)
- New aortic regurgitation murmur
- Rapid aneurysm expansion
- Syncope or pulse deficits
- Connective-tissue disorder with aortic root enlargement
Assessment
Differential diagnosis
- Degenerative/atherosclerotic aneurysm
- Marfan / Loeys-Dietz / vascular Ehlers-Danlos
- Bicuspid aortic valve aortopathy
- Post-stenotic dilatation
- Chronic aortic dissection
- Takayasu or giant cell aortitis
Investigations
- CT or MR angiography of the whole aorta
- Transthoracic echo for aortic root and ascending aorta
- Genetic testing if connective-tissue disorder suspected
- Blood pressure assessment
- Family history and screening of first-degree relatives
- Inflammatory markers if aortitis suspected
Management
- Measure aortic diameter at standardised levels and identify the aortopathy phenotype
- Assess for syndromic features and arrange genetic testing where indicated
- Control blood pressure strictly, typically with a beta-blocker and ARB
- Advise avoidance of heavy isometric straining and stimulant drugs
- Set surveillance imaging intervals based on size, aetiology and growth rate
- Refer for surgery at ≥5.5 cm (degenerative ascending), lower in connective-tissue disease
- Use lower thresholds (e.g. ≥4.5-5.0 cm) in Marfan, Loeys-Dietz, bicuspid with risk features, or family history of dissection
- Consider repair for rapid growth (>3-5 mm/year) or symptoms
- Combine root/ascending repair with aortic valve surgery when indicated
- Screen first-degree relatives in heritable aortopathy
- Counsel on pregnancy risk in connective-tissue aortopathy
- Maintain lifelong imaging surveillance
Drugs & doses
Bisoprolol 2.5-10 mg PO OD (reduce aortic wall stress)
Losartan 50-100 mg PO OD (ARB, particularly in Marfan)
Amlodipine 5-10 mg PO OD for additional BP control
Atorvastatin 20-80 mg PO OD if atherosclerotic aetiology
Disposition
Specialist aortic/cardiothoracic clinic; genetics referral for heritable disease. Emergency surgery for dissection or rupture.
Complications & pitfalls
- Acute aortic dissection
- Aneurysm rupture
- Aortic regurgitation from root dilatation
- Compression of adjacent structures
- Peri-operative stroke and spinal cord ischaemia
Exam pearls
- Surgical thresholds are lower in heritable aortopathy than in degenerative aneurysm
- Beta-blockers and ARBs reduce the rate of aortic growth in Marfan syndrome
- Bicuspid aortic valve warrants aortic imaging and family screening
- Index aortic size to body surface area, especially in small or tall patients
- Pregnancy markedly raises dissection risk in connective-tissue aortopathy
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.